Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.

Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, Huang S, Lan A, Zhang Y, Li J, Zhao D, Shen J, Wu H, He Y, Li H, Yang X.

Oncotarget. 2017 Jul 18;8(29):48488-48506. doi: 10.18632/oncotarget.17290. Review.

2.

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study.

White KA, Luo L, Thompson TA, Torres S, Hu CA, Thomas NE, Lilyquist J, Anton-Culver H, Gruber SB, From L, Busam KJ, Orlow I, Kanetsky PA, Marrett LD, Gallagher RP, Sacchetto L, Rosso S, Dwyer T, Cust AE, Begg CB, Berwick M; GEM Study Group.

Cancer Med. 2016 Nov;5(11):3336-3345. doi: 10.1002/cam4.929. Epub 2016 Oct 17.

3.

Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Taylor NJ, Thomas NE, Anton-Culver H, Armstrong BK, Begg CB, Busam KJ, Cust AE, Dwyer T, From L, Gallagher RP, Gruber SB, Nishri DE, Orlow I, Rosso S, Venn AJ, Zanetti R, Berwick M, Kanetsky PA; GEM Study Group.

Int J Cancer. 2016 Sep 15;139(6):1217-22. doi: 10.1002/ijc.30157. Epub 2016 May 30.

4.

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

J Natl Cancer Inst. 2016 Feb 8;108(7). pii: djw004. doi: 10.1093/jnci/djw004. Print 2016 Jul.

5.

A meta-analysis of XPD/ERCC2 Lys751Gln polymorphism and melanoma susceptibility.

Sun Y, Zhang H, Ying H, Jiang W, Chen Q.

Int J Clin Exp Med. 2015 Aug 15;8(8):13874-8. eCollection 2015.

6.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Thomas NE, Edmiston SN, Alexander A, Groben PA, Parrish E, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, From L, Busam KJ, Hao H, Orlow I, Kanetsky PA, Luo L, Reiner AS, Paine S, Frank JS, Bramson JI, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group.

JAMA Oncol. 2015 Jun;1(3):359-68. Erratum in: JAMA Oncol. 2015 Jun;1(3):285.

7.

Inherited genetic variants associated with occurrence of multiple primary melanoma.

Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):992-7. doi: 10.1158/1055-9965.EPI-14-1426. Epub 2015 Apr 2.

8.

Inherited variation at MC1R and histological characteristics of primary melanoma.

Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB, Dwyer T, Gallagher RP, Gruber SB, Orlow I, Rosso S, Thomas NE, Zanetti R, Rebbeck TR, Berwick M, Kanetsky PA.

PLoS One. 2015 Mar 19;10(3):e0119920. doi: 10.1371/journal.pone.0119920. eCollection 2015.

9.

Inherited variation at MC1R and ASIP and association with melanoma-specific survival.

Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, Rebbeck TR, Berwick M, Kanetsky PA; GEM Study Group.

Int J Cancer. 2015 Jun 1;136(11):2659-67. doi: 10.1002/ijc.29317. Epub 2014 Nov 26.

10.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Thomas NE, Kricker A, Waxweiler WT, Dillon PM, Busman KJ, From L, Groben PA, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Orlow I, Paine S, Ollila DW, Reiner AS, Luo L, Hao H, Frank JS, Begg CB, Berwick M; Genes, Environment, and Melanoma (GEM) Study Group.

JAMA Dermatol. 2014 Dec;150(12):1306-314.

11.

Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis.

He XF, Liu LR, Wei W, Liu Y, Su J, Wang SL, Shen XL, Yang XB.

PLoS One. 2014 May 6;9(5):e88490. doi: 10.1371/journal.pone.0088490. eCollection 2014.

12.

The association between RAD23B Ala249Val polymorphism and cancer susceptibility: evidence from a meta-analysis.

Li Z, Zhang Y, Ying X, Song J, Zhang R, Li Z, Chen H, Ye P, Shen Y, Pan W, Chen Z.

PLoS One. 2014 Mar 18;9(3):e91922. doi: 10.1371/journal.pone.0091922. eCollection 2014.

13.

Dupuytren's disease and the risk of malignant neoplasms.

Zyluk A, Paszkowska-Szczur K, Gupta S, Scott RJ, Lubiński J, Dębniak T.

Hered Cancer Clin Pract. 2014 Mar 6;12(1):6. doi: 10.1186/1897-4287-12-6.

14.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Groben PA, Hao H, Orlow I, Reiner AS, Luo L, Paine S, Ollila DW, Wilcox H, Begg CB, Berwick M.

J Clin Oncol. 2013 Nov 20;31(33):4252-9. doi: 10.1200/JCO.2013.51.3002. Epub 2013 Oct 14.

15.

Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.

Ogbah Z, Visa L, Badenas C, Ríos J, Puig-Butille JA, Bonifaci N, Guino E, Augé JM, Kolm I, Carrera C, Pujana MÁ, Malvehy J, Puig S.

BMC Med Genet. 2013 Feb 16;14:26. doi: 10.1186/1471-2350-14-26.

16.

Association between XPF polymorphisms and cancer risk: a meta-analysis.

Shi TY, He J, Qiu LX, Zhu ML, Wang MY, Zhou XY, Han J, Yu H, Zang RY, Wei Q.

PLoS One. 2012;7(7):e38606. doi: 10.1371/journal.pone.0038606. Epub 2012 Jul 2. Review.

17.

Ethnicity and cutaneous melanoma in the city of Sao Paulo, Brazil: a case-control study.

Luiz OC, Gianini RJ, Gonçalves FT, Francisco G, Festa-Neto C, Sanches JA, Gattas GJ, Chammas R, Eluf-Neto J.

PLoS One. 2012;7(4):e36348. doi: 10.1371/journal.pone.0036348. Epub 2012 Apr 27.

18.

Nonsteroidal anti-inflammatory drugs and risk of melanoma.

Jeter JM, Bonner JD, Johnson TM, Gruber SB.

J Skin Cancer. 2011;2011:598571. doi: 10.1155/2011/598571. Epub 2011 May 26.

19.

Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis.

Thomas NE, Kricker A, From L, Busam K, Millikan RC, Ritchey ME, Armstrong BK, Lee-Taylor J, Marrett LD, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Goumas C, Kanetsky PA, Begg CB, Orlow I, Wilcox H, Paine S, Berwick M; Genes, Environment, and Melanoma Study Group.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2932-41. doi: 10.1158/1055-9965.EPI-10-0686. Epub 2010 Aug 27.

20.

Oral contraceptives: a risk factor for squamous cell carcinoma?

Applebaum KM, Nelson HH, Zens MS, Stukel TA, Spencer SK, Karagas MR.

J Invest Dermatol. 2009 Dec;129(12):2760-5. doi: 10.1038/jid.2009.168. Epub 2009 Jun 25.

Supplemental Content

Support Center